Aberrant cell cycle machinery and loss of the CDKN2A tumor suppressor locus make CDK4/6 a potential target in pancreatic ductal adenocarcinoma (PDAC). This evidence concerns the gene CDK4 and pancreatic ductal adenocarcinoma.